BarbaraBurtness, Editor-in-Chief Barbara Burtness studied medicine at the State University of New York at Stony Brook, following graduation from Bryn Mawr College. She trained in internal medicine at Yale-New Haven Hospital and in medical oncology at Memorial-Sloan Kettering Cancer Center. She was Assistant and Associate Professor at Yale University (1993-2005), and worked at Fox Chase Cancer Center from 2005 to 2014, serving as Associate Director for Clinical Research and Section Chief of Head and Neck Oncology. She is Professor of Medicine at Yale University School of Medicine, and Co-Leader of the Developmental Therapeutics Program in the Yale Cancer Center. She is Chair of the Head and Neck Therapeutics Committee in ECOG-ACRIN. She co-edits the text Molecular Determinants of Head and Neck Cancer.
Barbara has research interests in drug development in head and neck cancer, resistance to EGFR inhibition, as well as the use of network modeling to target survival kinases in cancers with tumor suppressor gene mutation.